Aim: Attention-deficit/hyperactivity disorder is a heterogeneous neurobiological disorder that is characterized by inattention, impulsivity, and an increase in motor activity. Although methylphenidate has been used as a medication for decades, unknown is whether methylphenidate treatment can cause drug dependence in patients with attention-deficit/hyperactivity disorder. This study investigated the reward-enhancing effects of methylphenidate using intracranial self-stimulation in an animal model of attention-deficit/hyperactivity disorder, dopamine transporter knockout mice.
effects of MPH are less clear in DAT-KO mice. Thus, this study investigated the reward-enhancing effects of MPH using intracranial self-stimulation (ICSS) procedures in DAT-KO mice.
| MATERIALS AND METHODS

| Animals
Heterozygote-heterozygote matings of DAT-KO mice on a C57BL/ 6J background were used to produce wild-type and homozygous DAT-KO animals. 7 A maximum of 5 mice were housed per cage (one mouse per cage after surgery) in an environment at 23°C AE 1°C with 50% AE 5% relative humidity under a 12-hour/12-hour light/ dark cycle. Food and water were available ad libitum. Male and female mice (>20 weeks of age) were used for the experiments, which were conducted under the light phase of the light/dark cycle.
| Drugs
Methylphenidate and atomoxetine (ATX) were purchased from Sigma 
| Lateral hypothalamic ICSS test procedure
After a 7-day recovery period, the mice were trained to nosepoke for ICSS (0.5 seconds, 100 Hz, 100 lA bipolar square wave) using an ICSS apparatus (Med Associates, St. Albans, VT, USA; see Appendix S1 for details). The mice nosepoked >200 times for ICSS within 10 minutes after 3 training sessions (one training session per day, with >3 days, and between each session). Current amplitude manipulations were then introduced. The current was varied from 50 to 120 lA to determine the optimal current (ie, the weakest current that produced the maximal response rate for each mouse).
Lateral hypothalamic ICSS (lhICSS) responding was investigated after drug treatment using a progressive-ratio schedule 8 or a rate-frequency procedure 9 with the optimal current set for each mouse (see Appendix S1 for details). In the progressive-ratio procedure, the ICSS rate was defined as the percentage of the highest number of nosepokes during the experiment for each mouse. In the rate-frequency procedure, the nosepoke counts for each mouse were normalized to the maximum control rate, which was defined as the maximum rate that was observed at any stimulation frequency during the baseline rate-frequency determination. 
| Statistical analysis
The data are expressed as mean AE SEM. No significant differences were found between male and female mice in the ICSS procedures (see Tables S1 and S2) ; therefore, we pooled the data for male and female mice. The data were analyzed using two-way repeated-measures analysis of variance (ANOVA) followed by the Sidak multiple comparison post hoc test or Student's t test using Prism 7 software (GraphPad, La Jolla, CA, USA). Values of P < .05 were considered statistically significant.
| RESULTS
We assessed the reward-enhancing effects of MPH in DAT-KO and wild-type mice using the lhICSS procedure. In the progressive-ratio procedure, naive DAT-KO mice had a significantly higher maximum number of nosepokes in a session compared with naive wild-type mice (wild type: 135.0 AE 28.2; DAT-KO: 302.9 AE 51.7; Student's t test, t = 2.73, df = 13, P < .05). Similar to our previous study, 10 DAT-KO mice maintained a high level of ICSS responding and did not reach a progressive-ratio breakpoint. Thus, to evaluate the effects of MPH, we analyzed changes in the ICSS rate-ratio curve using two-way ANOVA (Figure 1 ). In wild-type mice, significant main effects of ratio and MPH treatment were found, with a significant ratio 9 MPH treatment interaction (two-way repeated-measures ANOVA; MPH treatment: F 3,21 = 5.70, P < .01; ratio: F 6,126 = 27.8, P < .001; MPH treatment 9 ratio interaction: F 18,126 = 2.74, P < .001; Figure 1a ). The Sidak multiple comparison post hoc test
showed that 5 and 10 mg/kg MPH significantly increased the rate of ICSS at ratios of 8, 16, and 32. In DAT-KO mice, MPH treatment at doses of 5-20 mg/kg did not affect the ICSS rate (two-way repeated-measures ANOVA; MPH treatment: F 3,30 = 1.80, P = .31; ratio: F 6,180 = 6.97, P < .001; MPH treatment 9 ratio interaction:
F 18,180 = 0.60, P = .90; Figure 1b) . These results showed that MPH at doses of 5-20 mg/kg facilitated reward-related behavior in wildtype mice but not in DAT-KO mice.
Although 20 mg/kg MPH did not significantly affect the ICSS rate, with the exception of ratio 1 in wild-type mice, this dose tended to slightly suppress the ICSS rate in both genotypes of mice. Thus to evaluate the higher dose beyond the therapeutic range of MPH and the selective NET inhibitor ATX, rate-frequency procedures were also performed. In wild-type mice, significant main effects of frequency and drug treatment were found, with a significant frequency 9 drug treatment interaction (two-way repeated-measures ANOVA; drug treatment: F 3,52 = 2.91, P < .05; frequency: F 6,312 = 7.76, P < .001; drug treatment 9 frequency interaction: F 18,312 = 4.01, P < .001; Figure 2a ). The Sidak multiple comparison post hoc test showed that the highest dose of MPH (60 mg/kg) significantly decreased the ICSS rate at frequencies of F I G U R E 1 Effects of MPH on ICSS rate in the progressive-ratio procedure in (A) wild-type mice (saline, n = 7; 5 mg/kg MPH, n = 6; 10 mg/kg MPH, n = 6; 20 mg/kg MPH, n = 6) and (B) DAT-KO mice (saline, n = 8; 5 mg/kg MPH, n = 9; 10 mg/kg MPH, n = 9; 20 mg/kg MPH, n = 8). Each mark and each vertical line represent the mean AE SEM. # P < .05, ## P < .01, ### P < .001, compared with saline-treated group F I G U R E 2 Effects of MPH and ATX on ICSS rate in the ratefrequency procedure in (A) wild-type mice (saline, n = 16; 20 mg/kg MPH, n = 8; 60 mg/kg MPH, n = 16; 20 mg/kg ATX, n = 16) and (B) DAT-KO mice (saline, n = 16; 20 mg/kg MPH, n = 14; 60 mg/kg MPH, n = 16; 20 mg/kg ATX, n = 16). Each mark and each vertical line represent the mean AE SEM.
